The results showed that the expression of SH3GL2 in glioma cell lines was dramatically decreased compared to the non‐tumorous cell line 293T, especially in U87 cell line with a higher degree of malignancy (Fig. 1E). The gene discussed is SH3GL2; the disease is central nervous system cancer.